Abstract
α4β7+ Tr17 and CD8+ T cells mediate immune-suppressive or immune-stimulatory effects for immune checkpoint blockade, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1158/2159-8290.cd-rw2023-095
Journal: Cancer Discovery | Publication Date: Jun 23, 2023 |
α4β7+ Tr17 and CD8+ T cells mediate immune-suppressive or immune-stimulatory effects for immune checkpoint blockade, respectively.
Join us for a 30 min session where you can share your feedback and ask us any queries you have